Several Cartiva toe implant lawsuits have been withdrawn in recent months, raising speculations about whether the manufacturer has reached settlements or entered tolling agreements with plaintiffs.
Some surgeons and other sources are reporting much higher Cartiva toe implant failure rates than were reported in clinical trials leading to the device's approval.
A new study links Cartiva toe implant surgery to an increased risk of post-operative pain when compared to other ways to address big toe arthritis.
A Cartiva SCI lawsuit claims the big toe arthritis implant is defectively designed, with a higher failure rate than the manufacturers have indicated.
The FDA is warning that Januvia and similar diabetes drugs may be causing cases of severe joint pain among users.
